MedTrace Logo

Cranial Blocks for Postoperative Anesthesia

NCT04749797 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2023-09-13

Study results available
· View outcomes & findings →

Summary

This study compares the standard of care to the standard of care plus the administration of bupivacaine or liposomal bupivacaine in patients receiving craniotomies.

Conditions

  • Craniotomy Surgery

Interventions

DRUG

Liposomal bupivacaine

Used as cranial block for craniotomy surgery

DRUG

Bupivacaine Injection

Used as cranial block for craniotomy surgery

DRUG

Saline

Used as cranial block for craniotomy surgery

Sponsors & Collaborators

Principal Investigators

  • Timothy H Lucas, MD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-02
Primary Completion
2021-07-20
Completion
2021-07-20
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04749797 on ClinicalTrials.gov